Zydus

Zydus Launches Denosumab Biosimilar ‘Zyrifa’ For Bone Health In Cancer Patients

Zydus Launches Denosumab Biosimilar ‘Zyrifa’ For Bone Health In Cancer Patients

11 Dec 2025

1 min read

Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of beta-thalassemia

Zydus receives USFDA Orphan Drug Designation (ODD) for Desidustat for the treatment of beta-thalassemia

06 Nov 2025

1 min read

Zydus Enters Canadian Market with Smoking Cessation Drug

Zydus Enters Canadian Market with Smoking Cessation Drug

08 Aug 2025

1 min read

Read More

Voice Of HealthCare

vohnetwork.com